Development Of A Novel Orally Active Peptide For The Treatment Of Pain
Funder
National Health and Medical Research Council
Funding Amount
$402,145.00
Summary
Chronic pain from damage to the nervous system is difficult to treat. A new type of drug has recently been developed from sea snail venom to treat chronic pain but is given by injection, which limits its use. Our research has developed a stable molecule that has analgesic activity when ingested. This proposal focuses on further testing to fully establish this molecule's therapeutic potential. This information can then attract a commercial partner to bring the new drug into general use.
Development Of The Quick Clinical On-line Evidence Based Decision Support System
Funder
National Health and Medical Research Council
Funding Amount
$124,500.00
Summary
Web information retrieval is of increasing importance to health professions. Yet, despite advances in technology, clinicians still have large unmet information needs with significant consequences for the public. QuickClinical is an evidence delivery system that utilises intelligent search filter technology to assist typical clinical tasks like ‘diagnosis’, ensuring only the most relevant evidence is retrieved. This grant will allow a research prototype to be taken to early commercialisation stag ....Web information retrieval is of increasing importance to health professions. Yet, despite advances in technology, clinicians still have large unmet information needs with significant consequences for the public. QuickClinical is an evidence delivery system that utilises intelligent search filter technology to assist typical clinical tasks like ‘diagnosis’, ensuring only the most relevant evidence is retrieved. This grant will allow a research prototype to be taken to early commercialisation stage, ready to be deployed in different environments for different clinical users.Read moreRead less
Evaluation Of Factor Va From The Venom Of The Australian Brown Snake As A Topical And Systemic Anti-bleeding Agent
Funder
National Health and Medical Research Council
Funding Amount
$113,742.00
Summary
Anti-bleeding agents are important pharmaceuticals for use in truama, surgery and several medical conditions to reduce blood loss and the need for blood transfusion. Some Australian snakes contain in their venom a powerful blood clotting agent. This agent mimics the human clotting machinery. In this project, we plan to test purified components of snake venom for an ability to clot human blood. We will undertake laboratory test-tube experiments as well as using an animal model after ethical appro ....Anti-bleeding agents are important pharmaceuticals for use in truama, surgery and several medical conditions to reduce blood loss and the need for blood transfusion. Some Australian snakes contain in their venom a powerful blood clotting agent. This agent mimics the human clotting machinery. In this project, we plan to test purified components of snake venom for an ability to clot human blood. We will undertake laboratory test-tube experiments as well as using an animal model after ethical approval. This project seeks to capture some of the genetic blueprint of an Australian snake, for human benefit by developing a new therapeutic agent based on a venom component. If the experiments are successful, the next stage will be further testing of efficacy and toxicity before seeking approval for clinical trials. The research is supported by the Australian pharmaceutical company QRx Pharma Pty Ltd who will work with Uniquest Pty Ltd to protect intellectual property generated in the project.Read moreRead less